BTCC / BTCC Square / Global Cryptocurrency /
Abbott Laboratories Boosts Dividend and Announces Major Acquisition, Strengthening 2026 Outlook

Abbott Laboratories Boosts Dividend and Announces Major Acquisition, Strengthening 2026 Outlook

Published:
2025-12-12 17:02:02
26
1
BTCCSquare news:

Abbott Laboratories (ABT) has reaffirmed its commitment to shareholder value with a 6.8% increase in its quarterly dividend, now at $0.63 per share. This marks 54 consecutive years of dividend growth, solidifying its position in the S&P 500 Dividend Aristocrats Index. The annual dividend rises to $2.52, yielding 1.91% at the current stock price of $123.69.

The company's $21 billion acquisition of Exact Sciences is poised to accelerate diagnostics revenue growth by approximately 300 basis points. UBS has reiterated its Buy rating, raising the price target to $158 following the deal announcement. Abbott's MedTech and diagnostics segments show robust momentum as the company heads into 2026.

|Square

Get the BTCC app to start your crypto journey

Get started today Scan to join our 100M+ users

All articles reposted on this platform are sourced from public networks and are intended solely for the purpose of disseminating industry information. They do not represent any official stance of BTCC. All intellectual property rights belong to their original authors. If you believe any content infringes upon your rights or is suspected of copyright violation, please contact us at [email protected]. We will address the matter promptly and in accordance with applicable laws.BTCC makes no explicit or implied warranties regarding the accuracy, timeliness, or completeness of the republished information and assumes no direct or indirect liability for any consequences arising from reliance on such content. All materials are provided for industry research reference only and shall not be construed as investment, legal, or business advice. BTCC bears no legal responsibility for any actions taken based on the content provided herein.